President Trump Secures New Deal to Lower Drug Prices for Americans
President Trump announced a deal with AstraZeneca to align U.S. drug prices with those of other developed nations, resulting in significant savings for American patients and Medicaid programs, while also investing $50 billion in U.S. pharmaceutical manufacturing and R&D. The agreement includes discounts on key medicines for asthma and COPD, and aims to end the practice of foreign countries subsidizing their healthcare through higher U.S. drug prices.